Morgan Stanley (MS)

Morgan Stanley is executing at a high level, delivering 62.4% YoY earnings growth and 28.0% revenue growth driven by a powerful rebound in investment banking activity, resilient wealth management fee income, and improving capital markets conditions. At 17.6x trailing and 15.7x forward P/E, the stock trades at a modest discount to its earnings power, with 21 analysts leaning Buy and a consensus price target implying ~10.5% upside. The key risk is cyclicality — a reversal in deal-making activity or equity market weakness could compress revenues and earnings materially in subsequent quarters.

• Investment banking pipeline recovery: A sustained rebound in M&A advisory and equity/debt underwriting volumes in H2 2025 could drive further upside to consensus estimates beyond the already-strong 62% earnings growth.
• Wealth Management AUM growth: Rising equity markets and continued net new asset inflows into the $5T+ wealth platform could accelerate fee-based revenue, providing durable non-cyclical earnings contribution.
• Capital return acceleration: With improved earnings and a strong capital position, an announced dividend increase or expanded share buyback program in the next quarterly earnings cycle could serve as a near-term price catalyst.

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →